277 related articles for article (PubMed ID: 7600865)
1. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
Feng BZ; Lei JL; Han JZ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
[TBL] [Abstract][Full Text] [Related]
2. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
3. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
5. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of sister chromatid differentiation in myelodysplastic syndrome and its clinical application].
Qian J; Xue Y; Yu F; Pan J; Wu Y
Zhonghua Nei Ke Za Zhi; 2002 Sep; 41(9):602-4. PubMed ID: 12421492
[TBL] [Abstract][Full Text] [Related]
7. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
10. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the occurrences of AL, MDS and AA and abnormal BM proliferation of patient's parents].
Feng BZ; Lei JL; Lin ZX; Shao ZH; Wang Q
Yi Chuan Xue Bao; 1998 Apr; 25(2):103-11. PubMed ID: 9752008
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
[TBL] [Abstract][Full Text] [Related]
15. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
16. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
[TBL] [Abstract][Full Text] [Related]
17. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
[TBL] [Abstract][Full Text] [Related]
19. Soluble transferrin receptor and its ratio to erythroblasts in bone marrow may be a new diagnostic tool to distinguish between aplastic and refractory anemia.
Matsuda A; Misumi M; Shimada T; Yoshida K; Yagasaki F; Ito Y; Kawai N; Murohashi I; Hirashima K; Bessho M
Acta Haematol; 2004; 111(3):138-42. PubMed ID: 15034234
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study on the early diagnosis of myelodysplastic syndromes.
Qian J; Xue Y; Yu F; Wu Y; Pan J; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):307-10. PubMed ID: 12411062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
